A roundtable was held recently at the 9th China International Import Expo, where disease control experts, clinicians and corporate representatives discussed moving disease prevention further upstream and better coordinating medical treatment with prevention.
Li Weidong, vice-president of GSK and head of its China vaccines business, said the company will work with local partners as well as public health and clinical professionals to better connect prevention, diagnosis and treatment, and chronic disease management, turning the concept of immunization into health actions that people can put into practice.
The effort comes in line with the Healthy China 2030 initiative, which emphasizes disease prevention and full-cycle health services.
Sun Xiaodong, deputy director of the Shanghai Municipal Center for Disease Control and Prevention, said China's immunization program is entering a new stage that covers the entire life cycle and the whole population, which calls for continued efforts in public health education and in making vaccination services more accessible.
Zheng Zihang contributed to this story.
